{
  "Variants Include": [
    {
      "Gene": "PINK1",
      "variants": [
        {
          "HGVS": "NM_018675.4:c.1327G>T",
          "cDNA Change": {
            "transcript": "NM_018675.4",
            "ref": "G",
            "alt": "T",
            "position": "1327"
          },
          "Protein Change": {
            "ref": "W",
            "alt": "X",
            "position": "442"
          },
          "Description in input context": "p.W437X"
        }
      ]
    },
    {
      "Gene": "ND5",
      "variants": [
        {
          "HGVS": "MT-TF:c.169G>A",
          "cDNA Change": {
            "transcript": "MT-TF",
            "ref": "G",
            "alt": "A",
            "position": "169"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "57"
          },
          "Description in input context": "c.169G>A (p.A57T)"
        }
      ]
    },
    {
      "Gene": "ND6",
      "variants": [
        {
          "HGVS": "MT-TF:c.410A>G",
          "cDNA Change": {
            "transcript": "MT-TF",
            "ref": "A",
            "alt": "G",
            "position": "410"
          },
          "Protein Change": {
            "ref": "N",
            "alt": "D",
            "position": "137"
          },
          "Description in input context": "c.410A>G (p.N137D)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Early-onset parkinsonism",
    "MONDO": "MONDO:0004972"
  },
  "Experiment Method": [
    {
      "Assay Method": "Mitochondrial DNA Analysis",
      "Material used": {
        "Material Source": "Human fibroblasts",
        "Material Name": "Patient-derived fibroblasts and mother's fibroblasts",
        "Description": "Fibroblasts from the patient and their mother were analyzed."
      },
      "Readout type": "Qualitative/Quantitative",
      "Readout description": [
        {
          "Variant": "MT-TF:c.169G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "N.D.",
          "Result Description": "Missense mutation in ND5 detected."
        },
        {
          "Variant": "MT-TF:c.410A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "N.D.",
          "Result Description": "Missense mutation in ND6 detected."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not mentioned in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not mentioned in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "Not mentioned in the literature."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not mentioned in the literature."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Not mentioned in the literature."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Normal mtDNA mutations not detected.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Abnormal mtDNA mutations detected.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes",
        "Description": "Mitochondrial DNA analysis is a standard method for studying parkinsonism."
      }
    },
    {
      "Assay Method": "Oxidative Phosphorylation Complex Analysis",
      "Material used": {
        "Material Source": "Human fibroblasts",
        "Material Name": "Patient-derived fibroblasts and mother's fibroblasts",
        "Description": "Fibroblasts from the patient and their mother were analyzed."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "PINK1:NM_018675.4:c.1327G>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "N.D.",
          "Result Description": "Reduced activity of oxidative phosphorylation complexes."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not mentioned in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not mentioned in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "Not mentioned in the literature."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not mentioned in the literature."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Not mentioned in the literature."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Normal oxidative phosphorylation complex activity observed.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Abnormal oxidative phosphorylation complex activity observed.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes",
        "Description": "Analysis of oxidative phosphorylation complexes is a standard method for studying parkinsonism."
      }
    }
  ]
}